ENTPD1 and acute myeloid leukemia: In support of a role for ATP dismantling in eliciting immune suppression in AML, another paper from Lecciso and colleagues reported that AML cells release ATP in response to chemotherapeutics and that through this they modulate dendritic cells and Tregs functions toward tolerance by upregulating CD39 expression on these subsets (150).